FATE THERAPEUTICS INC Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FATE THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in FATE THERAPEUTICS INC for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 14.16 | 941 | 13,326 | 1,526,203 | 1.5 M to 1.5 M (-0.06 %) |
| Jan 31 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 14.16 | 644 | 9,120 | 1,527,144 | 1.5 M to 1.5 M (-0.04 %) |
| Jan 31 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 14.16 | 1,834 | 25,973 | 1,527,788 | 1.5 M to 1.5 M (-0.12 %) |
| Jan 31 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 14.16 | 94,081 | 1,332,375 | 1,529,622 | 1.6 M to 1.5 M (-5.79 %) |
| Jan 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 13.78 | 675 | 9,303 | 1,623,703 | 1.6 M to 1.6 M (-0.04 %) |
| Jan 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 13.78 | 463 | 6,381 | 1,624,378 | 1.6 M to 1.6 M (-0.03 %) |
| Jan 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 13.78 | 1,316 | 18,138 | 1,624,841 | 1.6 M to 1.6 M (-0.08 %) |
| Jan 30 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 13.78 | 67,546 | 930,946 | 1,626,157 | 1.7 M to 1.6 M (-3.99 %) |
| Jan 29 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 14.14 | 868 | 12,275 | 1,693,703 | 1.7 M to 1.7 M (-0.05 %) |
| Jan 29 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 14.14 | 595 | 8,414 | 1,694,571 | 1.7 M to 1.7 M (-0.04 %) |
| Jan 29 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 14.14 | 1,693 | 23,942 | 1,695,166 | 1.7 M to 1.7 M (-0.10 %) |
| Jan 29 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 14.14 | 86,844 | 1,228,122 | 1,696,859 | 1.8 M to 1.7 M (-4.87 %) |
| Jan 23 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 16.28 | 381 | 6,203 | 1,783,703 | 1.8 M to 1.8 M (-0.02 %) |
| Jan 23 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 16.28 | 261 | 4,249 | 1,784,084 | 1.8 M to 1.8 M (-0.01 %) |
| Jan 23 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 16.28 | 743 | 12,097 | 1,784,345 | 1.8 M to 1.8 M (-0.04 %) |
| Jan 23 2019 | FATE | FATE THERAPEUTICS ... | Nashat Amir | Director | Sell | S | 16.28 | 38,098 | 620,285 | 1,785,088 | 1.8 M to 1.8 M (-2.09 %) |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Option Exercise | A | 16.55 | 500,000 | 8,275,000 | 500,000 | |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | Wolchko J Scott | President and CEO | Grant | A | 0.00 | 250,000 | 0 | 374,881 | 124.9 K to 374.9 K (+200.19 %) |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | Valamehr Bahram | Chief Development O ... | Option Exercise | A | 16.55 | 135,000 | 2,234,250 | 135,000 | |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | Valamehr Bahram | Chief Development O ... | Grant | A | 0.00 | 45,000 | 0 | 72,958 | 28 K to 73 K (+160.96 %) |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Option Exercise | A | 16.55 | 135,000 | 2,234,250 | 135,000 | |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Option Exercise | M | 2.90 | 12,451 | 36,108 | 123,149 | |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Option Exercise | M | 1.69 | 8,461 | 14,299 | 0 | |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Option Exercise | M | 1.69 | 2,080 | 3,515 | 0 | |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Option Exercise | M | 1.37 | 2,008 | 2,751 | 0 | |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Grant | A | 0.00 | 45,000 | 0 | 90,418 | 45.4 K to 90.4 K (+99.08 %) |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Sell | S | 16.00 | 25,000 | 400,000 | 45,418 | 70.4 K to 45.4 K (-35.50 %) |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Buy | M | 2.90 | 12,451 | 36,108 | 70,418 | 58 K to 70.4 K (+21.48 %) |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Buy | M | 1.69 | 8,461 | 14,299 | 57,967 | 49.5 K to 58 K (+17.09 %) |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Buy | M | 1.69 | 2,080 | 3,515 | 49,506 | 47.4 K to 49.5 K (+4.39 %) |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | TAHL CINDY | General Counsel and ... | Buy | M | 1.37 | 2,008 | 2,751 | 47,426 | 45.4 K to 47.4 K (+4.42 %) |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Option Exercise | A | 16.55 | 135,000 | 2,234,250 | 135,000 | |
| Jan 09 2019 | FATE | FATE THERAPEUTICS ... | Shoemaker Daniel D | Chief Scientific Of ... | Grant | A | 0.00 | 45,000 | 0 | 135,591 | 90.6 K to 135.6 K (+49.67 %) |